Zimberelimab is a fully human IgG4 anti-PD-1 monoclonal antibody with high affinity and selectivity. Zimberelimab shows antitumor activities and can be used for various cancers research including cervical cancer, non-small cell lung cancer and classical Hodgkins lymphoma.
Purity:
>98.0%
CAS Number:
[2259860-24-5]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
